57750-81-9Relevant articles and documents
Development of a triazolobenzodiazepine-based PET probe for subtype-selective vasopressin 1A receptor imaging
Aravind, Appu,Chen, Jiahui,Haider, Ahmed,Kuang, Shi,Liang, Steven H.,Ramesh, Perla,Ran, Chongzhao,Rong, Jian,Shao, Tuo,Shao, Yihan,Van, Richard S.,Xia, Xiaotian,Xiao, Zhiwei,Young, Larry J.,Zhao, Chunyu
, (2021/09/28)
Objectives: To enable non-invasive real-time quantification of vasopressin 1A (V1A) receptors in peripheral organs, we sought to develop a suitable PET probe that would allow specific and selective V1A receptor imaging in vitro and in vivo. Methods: We sy
ARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES
-
Page/Page column 25, (2011/10/13)
The present invention is concerned with aryl-cyclohexyl-tetraazabenzo[e]azulenes of formula I wherein R1, R2 and R3 are as described herein. The invention further provides methods for the manufacture of such compounds and
HETEROBIARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES
-
Page/Page column 28, (2011/11/06)
The present invention relates to heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes of formula I wherein R1, R2 and R3 are as described herein. The compounds according to the invention act as V1a receptor modulators, and in